Premium
Gyre Therapeutics Inc (GYRE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Gyre Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in the research, development, manufacturing, and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of F351 (Hydronidone) for the treatment of Nonalc... Gyre Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in the research, development, manufacturing, and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of F351 (Hydronidone) for the treatment of Nonalcoholic Steatohepatitis Treatment (NASH)-associated fibrosis. The Company is also advancing a diverse pipeline in the China through its indirect controlling interest in Gyre Pharmaceuticals, including ETUARY therapeutic expansions, F573, F528, and F230. The Company operates through two segments: Gyre Pharmaceuticals, and Gyre after the Contributions. The Gyre Pharmaceuticals has one major commercial drug product, ETUARY, and several product candidates in pre-clinical and clinical development. Gyre is a biopharmaceutical company focused on the development and commercialization of F351 for the treatment of non-alcoholic steatohepatitis-associated liver fibrosis in the United States. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -0.621890547264 | 8.04 | 9.19 | 7.89 | 196923 | 8.51786125 | CS |
| 4 | -3 | -27.2975432211 | 10.99 | 11.67 | 7.5802 | 419239 | 9.14569338 | CS |
| 12 | -1.93 | -19.4556451613 | 9.92 | 11.78 | 6.11 | 242408 | 8.86485979 | CS |
| 26 | -1.92 | -19.3743693239 | 9.91 | 14.4228 | 6.11 | 176633 | 9.50101415 | CS |
| 52 | -2.67 | -25.0469043152 | 10.66 | 19 | 6.11 | 119394 | 10.31429472 | CS |
| 156 | 0.99 | 14.1428571429 | 7 | 30.4 | 5.88 | 107838 | 12.70885989 | CS |
| 260 | 0.99 | 14.1428571429 | 7 | 30.4 | 5.88 | 107838 | 12.70885989 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
